Tryozi Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.6/10
Best for: the pharmacy named and a price that does not climb with dose
Tryozi scores highest on state availability and ease of access.
Semaglutide
then $279/mo ongoing
Tirzepatide
then $379/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Florida telehealth selling compounded GLP-1 injections at a flat price that does not rise with dose, naming all four of its 503A compounding pharmacies.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Tryozi
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
MEDVi
Best for: switching between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
Liv Body
Best for: compounded GLP-1 paired with a muscle-preservation supplement stack
Editorial score · methodology
Tryozi at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $139/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Tryozi
Each dimension is scored algorithmically from Tryozi’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.3/10At $279/mo, Tryozi runs about 65% above the $170 median for GLP-1 providers, and the first month drops to $139. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.5/10Tryozi offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.8/10Online intake and platform experience — consult included in the price; 6 platform features disclosed.
Trust & Safety15%
8.4/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy.
Accessibility10%
8.7/10Tryozi treats patients in all 50 states.
Support10%
6.3/10Tryozi provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Tryozi review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Tryozi
We walked Tryozi’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Pricing and plans are public on the homepage before any intake
- 2Check eligibility is advertised as free and taking 2 minutes
- 3Eligibility check opens in a new tab and is reviewed by licensed U.S. clinicians
- 4Plan choice is month-to-month or a 12, 24 or 52-week plan billed once
- Walked the public funnel only: no account was created, no health information was submitted and no payment step was reached
- Supply-chain transparency is the standout. The footer names four 503A compounding pharmacies by name rather than saying a licensed pharmacy
- The pricing page commits in writing that your monthly price does not jump as your dose increases
- The discount ladder is stated as percentages off, 22% at 12 weeks, 29% at 24 and 47% at 52, with the longer plans billed once upfront
- Compounded medications are not FDA-approved appears in the footer, which is a disclosure many competitors leave out
Tryozi customer support
- Phone
- (336) 365-0623
- support@tryozi.com
GLP-1 medications Tryozi offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
First 4 weeks $139 (50% off), then $279/mo. Multi-week plans are billed once and ship every 4 weeks: 12-week -22%, 24-week -29%, 52-week -47%.
First 4 weeks $189, then $379/mo, per the same first-month 50% structure.
Ready to get started?
Plans and promotions change often — check Tryozi's current pricing and active discounts before you decide.
What we like
- Names all four of its 503A compounding pharmacies: RedRock, Health Warehouse, Precision Medicine and Triad Rx
- Price does not increase as your dose increases, stated plainly on the pricing page
- Full total shown before payment, with the first-month discount and the ongoing rate both visible
- States plainly that compounded medications are not FDA-approved, a disclosure many competitors omit
- LegitScript certification verified against the issued seal, not just the badge
Watch-outs
- Headline $139 is a first-month half-price offer; the ongoing rate is $279
- Multi-week plans are billed once as a single upfront charge, not as a lower monthly rate
- Plans ship every 4 weeks, so a 52-week plan is 13 shipments rather than 12 months
- No refund policy detail is published on the pricing page itself
Is Tryozi worth it? Our verdict
Tryozi positions itself around one thing: the pharmacy named and a price that does not climb with dose. New patients start at $139/month for the first month, but the price settles at $279/month after that — so the headline is an intro offer, not the standing rate. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
On top of the prescription itself, Tryozi points to LegitScript Verified, Named Pharmacy, and Flat Dose Pricing.
How much Tryozi actually costs
- Compounded semaglutide — $139 first month, then $279/month
- Compounded tirzepatide — $189 first month, then $379/month
For context, the typical ongoing price across the GLP-1 providers we track is around $170/month, so Tryozi's standing rate sits at the premium end. The first-month discount is a great way to start cheaply, but price out the ongoing rate against a flat-rate provider before you commit long term.
For a direct comparison, Maximus runs semaglutide and tirzepatide from $249.99/month — worth pricing against Tryozi before you commit.
Medications: what Tryozi prescribes
Tryozi prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy — the reason the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who Tryozi is best for — and who should skip it
A good fit if you…
- want the cheapest possible way to start a GLP-1 and see how you respond before committing.
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like Collective will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Tryozi treats patients in all 50 states, and dispenses through an accredited compounding pharmacy. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Tryozi is one of the easiest ways to start a GLP-1 cheaply — just go in clear-eyed that the $139 intro price steps up to $279/month once the first month is behind you. Use that window to confirm the medication works for you, then re-check the ongoing math before you settle in. If you're comparison-shopping, MangoRx is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Tryozi scores highest on state availability and ease of access.
Ready to start with Tryozi?
Starting at $139/month. See current pricing and start your free consultation.
Tryozi might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider MEDVi.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Tryozi review:
Sources & methodology — as of September 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Tryozi's current pricing
Plans start at $139/month. Start your free consultation to check eligibility and today's price.